Dana M. Lewis | #OpenAPS 🤖 Profile picture
Mar 15, 2020 10 tweets 4 min read Read on X
Here's a list of questions and responses (some existing threads, some new info to Twitter) about what I've been being asked by friends and family about what I've been doing and what they've should be thinking about doing re: #COVID19 protection measures.

Thread:
Q: Are you still social distancing?

A: Yes. I'm on day 21 of social distancing. No restaurants, no seeing family unless we are out in the fresh air separated by 6+ feet with no contact. No other contact other than @scottleibrand.

Details here:
Note: if you social distance for ~14 days & do not have symptoms, that makes your bubble safe. If someone or some other household is also equally stringent & develops a safe bubble, those bubbles can then interact. So you can buddy up if people are willing to take equal measures.
(My 6yo niece: what have you DONE for three weeks at home?
Me:😂I'm working at home, taking a walk or running every day, reading, etc. (plus working on #CoEpi))
Q: What do I think my risk is as a person with diabetes?

A: I laid out how I'm assessing my risk of severe outcomes from #COVID19 here:

A: Regardless of personal risk,I'm also doing everything I can (see above, major social distancing) to protect others
A: for more info with tips on social distancing, especially for people who live alone or need help, and more information for people with diabetes, see this article: diatribe.org/coronavirus-pr…
Q: Should I stay home? I'm healthy.

A: YES. There is a lot of community transmission in many places. Remember, many people transmit & get other people ill before they start getting #COVID19 symptoms. Stay home now if you can, prevent transmission even if you think you're healthy Image
Q: What about routine health appointments?

A: I plan to reschedule a March 31 dentist appointment. I am due in April for a yearly endo appt - planning to reschedule and hoping insurance will waive requirement for fresh/recent chart notes if I need rx for diabetes supplies.
(Not asked directly, but tied in with the above rescheduling - I want/need a haircut, and I'm also planning to go without for a few months. Any non-urgent appointment or errand etc is being rescheduled.)

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Dana M. Lewis | #OpenAPS 🤖

Dana M. Lewis | #OpenAPS 🤖 Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @danamlewis

Jun 22
1/ What if there was a tool to help identify who might have exocrine pancreatic insufficiency (EPI/PEI)?

EPI is a significant issue for many people with diabetes (likely more common than gastroparesis or celiac).

Here's how such a tool can help PWD👇🏼🧵

#ADASciSessions #ADA2024
2/ The Exocrine Pancreatic Insufficiency Symptom Score (EPI/PEI-SS) has 15 symptoms, rated by how frequent they are and how bothersome they are (aka severity).

n=324 ppl participated in a real-world survey.

n=118 were people with diabetes (PWD)!

#ADASciSessions #ADA2024
3/ Methods:

EPI/PEI-SS scores were analyzed and compared between PWD (n=118), with EPI (T1D: n=14; T2D: n=20) or without EPI (T1D: n=78; T2D: n=6), and people without diabetes (n=206) with and without EPI.

#ADASciSessions #ADA2024
Read 10 tweets
Jun 6, 2022
📣 Presentation of the primary outcome results from the CREATE Trial, which assessed open source automated insulin delivery (AID) compared to sensor-augmented pump therapy (SAPT) in adults & kids with T1D, at #ADA2022!

@DrMartindeBock1 presenting on behalf of CREATE team.

1/
Shout out to the amazing CREATE study team.

(PS - there’s another publication from our team about HCPs learning experience on open source AID for this study, too! doi.org/10.1111/dme.14…)

2/ #ADA2022
The CREATE trial aimed to study the efficacy and safety of an open source automated insulin delivery system, with a large scale, long term randomized controlled trial.

3/ #ADA2022
Read 15 tweets
Jun 5, 2022
I just realized it's been 3 (!) years since I published my book on automated insulin delivery, with the goal of helping increased conversation and understanding of AID technology for people with diabetes, their loved ones, and healthcare providers!

I'm still very proud that it is available to read for free online, free to download a PDF (both of which have been done thousands of times each: ArtificialPancreasBook.com), or as an e-book, paperback, and now hardback copy. Proceeds from the purchased copies go to Life For A Child.
And, more recently, it has also been translated into French by the wonderful Dr. Mihaela Muresan and Olivier Legendre!

The French translation is available in Kindle, paperback, hardback, or free PDF download formats as well.

Read 6 tweets
Sep 24, 2020
1/THREAD - my presentation is kicking off at #EASD2020 about open source automated insulin delivery.

(You can see a full version of my presentation here: bit.ly/DanaMLewisEASD…, or read the summary below!)
Note we should differentiate between open source (where the source of something is open), and DIY (do-it-yourself) implementations of open source code. Open source means it can be reviewed and used by individuals (thus, DIY or #DIYAPS) or by companies.

/2 #EASD2020
Open source automated insulin delivery (AID) has evolved since the first open source system, #OpenAPS, was made available in Feb 2015!

There are now three open source AID systems (OpenAPS, Loop, AndroidAPS) commonly used by the #DIYAPS community.

/3 #EASD2020
Read 25 tweets
Jun 13, 2020
THREAD:

Poster 988-P at #ADA2020 by Jennifer Zabinsky, Haley Howell, Alireza Ghezavati, @DanaMLewis Andrew Nguyen, and Jenise Wong: “Do-It-Yourself Artificial Pancreas Systems Reduce Hyperglycemia Without Increasing Hypoglycemia”

(PDF available at bit.ly/DanaMLewisADA2…)
This was a retrospective double cohort study that evaluated data from the @OpenAPS Data Commons (data ranged from 2017-2019) and compared it to conventional sensor-augmented pump (SAP) therapy from the @Tidepool_org Big Data Donation Project. #ADA2020
One month of CGM data (with more than 70% of the month spent using CGM), as long as they were >1 year of living with T1D, was used from the @OpenAPS Data Commons. People could be using any type of DIYAPS (OpenAPS, Loop, or AndroidAPS) and there were no age restrictions. #ADA2020
Read 12 tweets
Jun 13, 2020
THREAD:

Poster 99-LB at #ADA2020 by @danamlewis, @azure_dominique, and Lance Kriegsfeld, “Multi-Timescale Interactions of Glucose and Insulin in Type 1 Diabetes Reveal Benefits of Hybrid Closed Loop Systems“

(full content also available at bit.ly/DanaMLewisADA2…) Image
Background - Blood glucose and insulin exhibit coupled biological rhythms at multiple timescales, including hours (ultradian, UR) and the day (circadian, CR) in individuals without diabetes. But, biological rhythms in longitudinal data have not been mapped in T1D. #ADA2020
It is not known exactly how glucose and insulin rhythms compare between T1D and non-T1D, and whether rhythms are affected by type of therapy (Sensor Augmented Pump (SAP) or Hybrid Closed Loop (HCL)). #ADA2020
Read 26 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(